DNAprint Genomics (DNAG)

[frogdreaming]

mingwan, You can if you want, but it's less than helpful.

I would assume that you are implying that the Orchid option has, in fact, been transfered to Backman but you are constrained from actually saying so by some form of non-disclosure limitation.

As you will also be unable to confirm this assumption, that gets us nowhere.

Although it does beg some serious questions.

If the information is covered by non-disclosure constraints then it is also definitely NOT in the public domain. If it is proprietery information then the posting of it to a message board was highly irregular, and possibly a SEC violation.

Under the circumstances perhaps it would be better for you to refrain from referencing such a questionable post in the future, in order that you not be tainted by being associated with such an alarming attempt to improperly influence investor opinion.

regards,
frog